Expression of concern
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Paper Information
Record ID:
35124
Author(s):
Journal:
Publication Date:
December 01, 2012
Retraction Date:
January 24, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Medicine 1, Agaplesion Markus Hospital, Wilhelm-Epstein-Str. 4, D-60431 Frankfurt/Main, Germany
- Division of Gastroenterology, Department of Medicine, MtSinai Hospital and University Health Network
- University of Toronto, 600 University Avenue, Toronto, ON, Canada
- M5G 1X5 and University of Leuven, Belgium
Countries:
Article Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1093/ecco-jcc/jjab227Additional Notes:
See also: https://doi.org/10.1093/ecco-jcc/jjab225 Journal was previously published by Elsevier until 2015.
Citations (1561)
1561
Total Citations239
Post-Retraction(15.3%)
1316
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
9
Within 30 days
111
Within 1 year
61
After 2+ years
1218
Days since retraction (latest)
Nutrition and Supplementation in Ulcerative Colitis
Marcelina Radziszewska, Joanna Smarkusz-Zarzecka, Lucyna Ostrowska et al. (4 authors)
Nutrients
Open Access
Published: Jun 2022
69 citations
69 citations
141 days after retraction
Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
Shun-Wen Hsiao, Hsu‐Heng Yen, Yang‐Yuan Chen
Gut and Liver
Open Access
Published: Jun 2022
18 citations
18 citations
134 days after retraction
Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis
Weitao Hu, Taiyong Fang, Xiaohong Chen
Frontiers in Genetics
Open Access
Published: Jun 2022
17 citations
17 citations
129 days after retraction
Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
Soo‐Young Na, Chang Hwan Choi, Eun Mi Song et al. (14 authors)
Intestinal Research
Open Access
Published: May 2022
44 citations
44 citations
126 days after retraction
Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center
Sami Evirgen, Raım Iliaz, Filiz Akyüz et al. (13 authors)
The Turkish Journal of Gastroenterology
Open Access
Published: May 2022
8 citations
8 citations
122 days after retraction
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression—risks, screening, diagnosis and management
Sasha R. Fehily, Aysha Al‐Ani, Jonathan Abdelmalak et al. (12 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: May 2022
38 citations
38 citations
116 days after retraction
Investigation on the Inhibitory Effect of Wnt-5a on Colonic Mucosal Inflammation in Patients with Ulcerative Colitis
Kazuhiko Uchiyama, Tomohisa Takagi, Katsura Mizushima et al. (21 authors)
Digestive Diseases and Sciences
Published: May 2022
4 citations
4 citations
115 days after retraction
Antibiotics for the induction and maintenance of remission in ulcerative colitis
Morris Gordon, Vassiliki Sinopoulou, Ciaran Grafton‐Clarke et al. (4 authors)
Cochrane library
Open Access
Published: May 2022
21 citations
21 citations
114 days after retraction
Morus macroura Miq. Fruit extract protects against acetic acid-induced ulcerative colitis in rats: Novel mechanistic insights on its impact on miRNA-223 and on the TNFα/NFκB/NLRP3 inflammatory axis
Rania M. Salama, Samar F. Darwish, Ismail El Shaffei et al. (7 authors)
Food and Chemical Toxicology
Published: May 2022
19 citations
19 citations
113 days after retraction
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the <scp>IG‐IBD LIVE</scp> study
Daniela Pugliese, Giuseppe Privitera, Federica Crispino et al. (25 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: May 2022
40 citations
40 citations
108 days after retraction
Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review
Bipadabhanjan Mallick, Sarthak Malik
Cureus
Open Access
Published: May 2022
10 citations
10 citations
106 days after retraction
Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain
Xavier Calvet, Julián Panés, Javier Gallardo-Escudero et al. (42 authors)
Journal of Crohn s and Colitis
Open Access
Published: May 2022
15 citations
15 citations
105 days after retraction
The Role of Inflammation in Anal Cancer
Amir Selimagić, Ada Đozić, Azra Husic-Selimovic et al. (8 authors)
Diseases
Open Access
Published: May 2022
5 citations
5 citations
102 days after retraction
Therapy Strategies for Children Suffering from Inflammatory Bowel Disease (IBD)—A Narrative Review
Corinne Légeret, Raoul I. Furlano, Henrik Köhler
Children
Open Access
Published: Apr 2022
6 citations
6 citations
92 days after retraction
Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada
Elisabetta Fenu, Vasily Lukyanov, Annabel Acs et al. (8 authors)
PharmacoEconomics - Open
Open Access
Published: Apr 2022
8 citations
8 citations
92 days after retraction
Chinese Herb Injections in the Adjuvant Treatment for Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials
Ziyang Zhou, Hao Chen, Yingkai Shen et al. (4 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Apr 2022
2 citations
2 citations
88 days after retraction
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Francesca Ferretti, Rosanna Cannatelli, Maria Camilla Monico et al. (5 authors)
Journal of Clinical Medicine
Open Access
Published: Apr 2022
78 citations
78 citations
86 days after retraction
Qingchang decoction retention enema may induce clinical and mucosal remission in left-sided ulcerative colitis: A case report
Pei-Han Li, Yu Tang, Hong-Zhu Wen
World Journal of Clinical Cases
Open Access
Published: Apr 2022
2 citations
2 citations
73 days after retraction
Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis
Morris Gordon, Vassiliki Sinopoulou, Anthony K Akobeng et al. (6 authors)
Cochrane library
Open Access
Published: Apr 2022
13 citations
13 citations
73 days after retraction
Exposure‐Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance Studies
Arnab Mukherjee, Shinichi Tsuchiwata, Timothy Nicholas et al. (8 authors)
Clinical Pharmacology & Therapeutics
Open Access
Published: Apr 2022
8 citations
8 citations
71 days after retraction
Efficacy and safety of vedolizumab for pediatrics with inflammatory bowel disease: a systematic review
Shengbo Fang, Yanqing Song, Chunyan Zhang et al. (4 authors)
BMC Pediatrics
Open Access
Published: Apr 2022
15 citations
15 citations
70 days after retraction
Beneficial Effects of Celastrol on Immune Balance by Modulating Gut Microbiota in Experimental Ulcerative Colitis Mice
Mingyue Li, Weina Guo, Yalan Dong et al. (18 authors)
Genomics Proteomics & Bioinformatics
Open Access
Published: Apr 2022
34 citations
34 citations
67 days after retraction
Medication Adherence and Its Influencing Factors Among Inflammatory Bowel Disease Patients in China
Fen Xu, Juping Tang, Zhiping Zhu et al. (8 authors)
International Journal of General Medicine
Open Access
Published: Apr 2022
11 citations
11 citations
67 days after retraction
Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?
Gustavo Drügg Hahn, Petra A. Golovics, Panu Wetwittayakhlang et al. (6 authors)
Biomedicines
Open Access
Published: Mar 2022
10 citations
10 citations
58 days after retraction
Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives
Giorgia Meineri, Elisa Martello, E. Radice et al. (9 authors)
Animals
Open Access
Published: Mar 2022
11 citations
11 citations
58 days after retraction
Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
Oliwia Zakerska‐Banaszak, Liliana Łykowska‐Szuber, Michał Walczak et al. (6 authors)
Toxics
Open Access
Published: Mar 2022
15 citations
15 citations
57 days after retraction
Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
Katsuyoshi Matsuoka, Kanae Togo, Noritoshi Yoshii et al. (5 authors)
Intestinal Research
Open Access
Published: Mar 2022
11 citations
11 citations
45 days after retraction
Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis
J E A O'Connell, Jayne Doherty, Amy Buckley et al. (15 authors)
Intestinal Research
Open Access
Published: Mar 2022
3 citations
3 citations
45 days after retraction
Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
Hanyang Lin, Zhaohui Bai, Qiong Wu et al. (7 authors)
Frontiers in Public Health
Open Access
Published: Mar 2022
26 citations
26 citations
45 days after retraction
Dehydrocostus Lactone Suppresses Dextran Sulfate Sodium-Induced Colitis by Targeting the IKKα/β-NF-κB and Keap1-Nrf2 Signalling Pathways
Yun Yuan, Qiongying Hu, Lu Liu et al. (10 authors)
Frontiers in Pharmacology
Open Access
Published: Mar 2022
12 citations
12 citations
42 days after retraction
Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center
Jun Shen, Jie Liang, Ren Mao et al. (4 authors)
Inflammatory Bowel Diseases
Published: Mar 2022
4 citations
4 citations
40 days after retraction
Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, <scp>OCTAVE</scp> open
Remo Panaccione, María T. Abreu, Irina Lazariciu et al. (9 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: Mar 2022
8 citations
8 citations
40 days after retraction
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
Angelo Viscido, Marco Valvano, Gianpiero Stefanelli et al. (9 authors)
BMC Gastroenterology
Open Access
Published: Mar 2022
26 citations
26 citations
38 days after retraction
Subcutaneous golimumab to treat a biological naïve chronically active ulcerative colitis child. A case report
Marouf Alhalabi, Ahmad Abbas
Annals of Medicine and Surgery
Open Access
Published: Mar 2022
1 citation
1 citation
36 days after retraction
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study
Mariangela Allocca, Cecilia Dell’Avalle, Vincenzo Craviotto et al. (10 authors)
United European Gastroenterology Journal
Open Access
Published: Mar 2022
38 citations
38 citations
36 days after retraction
The Colon Wall Thickness Measured Using Transabdominal Ultrasonography Is Useful for Detecting Mucosal Inflammation in Ulcerative Colitis
Masahiro Takahara, Sakiko Hiraoka, Masayasu Ohmori et al. (14 authors)
Internal Medicine
Open Access
Published: Feb 2022
6 citations
6 citations
25 days after retraction
Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study
Ji Li, Zhanju Liu, P. Hu et al. (15 authors)
BMC Gastroenterology
Open Access
Published: Feb 2022
12 citations
12 citations
11 days after retraction
Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data
Bernd Bokemeyer, Nils Picker, Thomas Wilke et al. (5 authors)
Inflammatory Bowel Diseases
Open Access
Published: Feb 2022
16 citations
16 citations
11 days after retraction
Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting
Markus Ries, Brice Moulari, Maryam A. Shetab Boushehri et al. (8 authors)
Pharmaceutics
Open Access
Published: Feb 2022
13 citations
13 citations
9 days after retraction
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
Édouard Louis, Kristine Paridaens, Sameer Al Awadhi et al. (13 authors)
BMJ Open Gastroenterology
Open Access
Published: Feb 2022
19 citations
19 citations
8 days after retraction
Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort
Simen Vatn, Jonas Christoffer Lindstrøm, Aina Elisabeth Fossum Moen et al. (19 authors)
Clinical and Experimental Gastroenterology
Open Access
Published: Feb 2022
12 citations
12 citations
8 days after retraction
SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis
Marouf Alhalabi, Kamal Alaa Eddin, Fadwa Ali et al. (4 authors)
Medicine
Open Access
Published: Jan 2022
3 citations
3 citations
4 days after retraction
CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
Motahareh Arjomandnejad, Acadia L. Kopec, Allison M. Keeler
Biomedicines
Open Access
Published: Jan 2022
76 citations
76 citations
2 days after retraction
Impact of thiopurine discontinuation at anti‐tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study
Sandra Bohn Thomsen, Ryan C. Ungaro, Kristine H. Allin et al. (8 authors)
Alimentary Pharmacology & Therapeutics
Published: Jan 2022
6 citations
6 citations
1 days after retraction
Letter to the Editor
Laurent Peyrin‐Biroulet, Britta Siegmund, Silvio Danese et al. (7 authors)
Journal of Crohn s and Colitis
Open Access
Published: Jan 2022
Same day as retraction
Vagus Nerve Stimulation Reduces Indomethacin-Induced Small Bowel Inflammation
April S. Caravaca, Yaakov A. Levine, Anna R. Drake et al. (5 authors)
Frontiers in Neuroscience
Open Access
Published: Jan 2022
20 citations
20 citations
12 days before retraction
Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis
Silvio Danese, Barrett G. Levesque, Brian G. Feagan et al. (16 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: Jan 2022
29 citations
29 citations
14 days before retraction
Impact of treatment with immunomodulators and tumour necrosis factor antagonists on the incidence of infectious events in patients with inflammatory bowel disease
Per Ola Andersson, Pontus Karling
Upsala Journal of Medical Sciences
Open Access
Published: Jan 2022
3 citations
3 citations
14 days before retraction
A systematic review and meta-analysis of the prevalence of poor sleep in inflammatory bowel disease
Alex Barnes, Réme Mountifield, Justin N. Baker et al. (8 authors)
SLEEP Advances
Open Access
Published: Jan 2022
18 citations
18 citations
23 days before retraction
Value-based care pathway for inflammatory bowel disease: a protocol for the multicentre longitudinal non-randomised parallel cluster IBD Value study with baseline period
Reinier C A van Linschoten, Nikki van Leeuwen, Daan Nieboer et al. (11 authors)
BMJ Open
Open Access
Published: Jan 2022
5 citations
5 citations
23 days before retraction
Quick Stats
Total Citations:
1561
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025